Register and share your invite link to earn from video plays and referrals.

Search results for NBSフォーカス信州
NBSフォーカス信州 community
One keyword maps to one global community path.
Create community
People
Not Found
Tweets including NBSフォーカス信州
CHINA NBS OFFICIAL: EXPECTS MACRO POLICY MEASURES AFTER POLITBURO MEETING TO GAIN TRACTION
China has solid conditions to achieve annual growth target - NBS
New home prices in China's first-tier cities stayed relatively flat in July, NBS data showed today. Shanghai, Guangzhou, and Shenzhen saw new home prices climb by 0.2%, 0.1%, and 0.2%, respectively, from June, while Beijing reported a dip of 0.3%.
Show more
China's value-added industrial output grew 4.5% in July from a year earlier, the NBS said today. The figure increased 5.3% in the first seven months from the same period a year ago.
Show more
A FULL ACCOUNT OF MR. OFWONO OPONDO’S CRIME OF UTMOST SAVAGERY AT THE NBS TV FRONTLINE TALKSHOW
China's urban unemployment rate averaged 5.2% in the first seven months, within the annual target of 5.5%, according to data released by the NBS today. In July alone, the figure rose 0.2 percentage points from the previous month to 5.2% due to seasonal factors.
Show more
China's fixed asset investment slumped 6.7% in the first seven months from a year earlier to CNY26.03 trillion (USD3.86 trillion), the NBS said today. Investment in intellectual property jumped 9.1%, while private fixed-asset investment plunged 9.4%.
Show more
China’s retail sales of consumer goods climbed 1.2% in the first seven months from the same period last year to CNY28.78 trillion (USD4.27 trillion), the NBS said today. Excluding automobiles, the figure advanced 2.7% to CNY26.51 trillion (USD3.93 trillion). Retail sales of consumer goods edged up 0.6% to CNY3.9 trillion (USD578 billion) in July.
Show more
Naturally pretty but when I put myself together it's a different type of pretty going on. Nbs
GENEDX $WGS Q3’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $123.1M (Est. $123M) 🟡; +5% YoY 🔹 Adj. EPS: $0.28 (Est. $0.07) 🟢 🔹 GAAP EPS: -$0.41 🔹 Exome & Genome Revenue: $110.4M; +12% YoY 🔹 Exome & Genome Volume: 32,134; +25% YoY 🔹 Non-GAAP Gross Margin: 72%; -200 bps YoY FY26 Guide: 🔹 Revenue: $475M-$490M (Est. $482M) 🟡 🔹 Exome & Genome Revenue Growth: At least 17% 🔹 Exome & Genome Volume Growth: At least 28% 🔹 Adjusted Gross Margin: ~71% 🔹 Adjusted Net Income: ~$12M Q4 Guide: 🔹 Revenue: $135M 🔹 Exome & Genome Revenue: $121M 🔹 Exome & Genome Volume: 34,500 tests 🔹 Adjusted Gross Margin: At least 71% 🔹 Adjusted Net Income: ~$12M Customers & Assets: 🔹 Accession Growth: +28% YoY Announcements: 🔹 GUARDIAN Study: 30,000 newborns enrolled; 72.3% parental participation 🔹 BRIDGES-NBS: Screen up to 30,000 newborns for 700+ conditions over two years Key Updates: 🔹 Adjusted Net Income: $8.6M 🔹 Medicaid Coverage: 25 state programs now cover whole genome sequencing 🔹 ASHG: 27 scientific abstracts presented Comments: 🔸 “Our Q3 results reflect profitable execution in a growing market, as we translate the rising demand for exome and genome testing into durable revenue growth” 🔸 “Our priorities are clear: improve the economics of our testing, expand utilization, and deliver leading products at scale.”
Show more